Gliomas, the most prevalent primary brain tumors, pose considerable challenges due to their
heterogeneity, intricate tumor microenvironment (TME), and blood‐brain barrier (BBB) …

The emerging strategy of biomimetic nanoparticles (NPs) via cellular membrane camouflage
holds great promise in cancer therapy. This scholarly review explores the utilization of …

In recent times, the intersection of nanotechnology and biomedical research has given rise
to nanobiomedicine, a captivating realm that holds immense promise for revolutionizing …

Glioblastoma (GBM), a highly aggressive form of brain cancer, is considered one of the
deadliest cancers, and even with the most advanced medical treatments, most affected …

One of the main concerns in oligonucleotide-based therapeutics is achieving a successful
cell targeting while avoiding drug degradation and clearance. Nanoparticulated drug …

Fenton/Fenton-like reaction induced chemical dynamic therapy (CDT) has been widely
recognized in tumor therapy. Due to the low efficiency of conversion from high-valent metal …

Photodynamic therapy (PDT) is a promising strategy for effective cancer treatment. However,
it still faces severe challenges, including poor laser penetration and insufficient oxygen (O 2) …

IDH wild-type glioblastoma (GBM) intrinsic subtypes have been linked to different molecular
landscapes and outcomes. Accurate prediction of molecular subtypes of GBM is very …

Glioblastoma is the most common and lethal central nervous system malignancy with a
median survival after progression of only 6–9 months. Major biochemical mechanisms …

Tumor models in vitro are conventional methods for developing anti-cancer drugs,
evaluating drug delivery, or calculating drug efficacy. However, traditional cell line-derived …